Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infants

Clinical trial NCT05759520 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05759520
Sponsor: Fosun Adgenvax Biopharmaceutical Co.,Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Streptococcus Pneumoniae Infection

Start date: 2022-11-04
Primary completion: 2025-06-30
Enrollment: 1800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.